Non-impactor-based methods for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs)

AAPS PharmSciTech

Volumn 12, Issue 3, 2011, Pages 965-988

  Mitchell, Jolyon ^a   Bauer, Richard ^b   Lyapustina, Svetlana ^c   Tougas, Terrence ^d   Glaab, Volker ^e  

^a TRUDELL MEDICAL INTERNATIONAL   (Canada)

^b MannKind Corporation   (United States)

^c Pharmaceutical Practice Group   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

aerosol; efficient data analysis; measurement techniques; size distribution; spray

Indexed keywords

NOSE SPRAY;

AEROSOL; ANTENNA; COST BENEFIT ANALYSIS; HUMAN; IMAGE ANALYSIS; LASER; MICROSCOPY; PARTICLE SIZE; PHARMACEUTICS; PRIORITY JOURNAL; QUALITY CONTROL; REACTOR CASCADE; REVIEW;

ADMINISTRATION, INHALATION; AEROSOLS; EQUIPMENT DESIGN; HUMANS; MATERIALS TESTING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUSPENSIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 80052605561     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9662-6     Document Type: Review

References (93)

1. JP Mitchell MW Nagel 2003 Cascade impactors for the size characterization of aerosols from medical inhalers. Their uses and limitations J Aerosol Med. 16 4 341 77 10.1089/089426803772455622 14977427 10.1089/089426803772455622 1:CAS:528:DC%2BD2cXltFagtw%3D%3D (Pubitemid 38120942)
2. D Christopher P Curry W Doub K Furnkranz M Lavery K Lin, et al. 2003 Considerations for the development and practice of cascade impaction testing including a mass balance failure investigation tree J Aerosol Med. 16 3 235 47 10.1089/089426803769017604 14572321 10.1089/089426803769017604 (Pubitemid 37169634)
3. M Bonam D Christopher D Cipolla B Donovan D Goodwin S Holmes, et al. 2008 Minimizing variability of cascade impaction measurements in inhalers and nebulizers AAPS PharmSciTechnol 9 2 404 13 10.1208/s12249-008-9045-9 10.1208/s12249-008-9045-9 1:CAS:528:DC%2BC3cXnslGjtrk%3D
4. US Food Drug Administration. Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations. September 2006. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm070337.pdf. Accessed 2 Nov 2010.
5. JD Suman BL Laube R Dalby 1999 Comparison of nasal deposition and clearance of aerosol generated by a nebulizer and an aqueous spray pump Pharm Res 16 1648 52 10554112 10.1023/A:1011933410898 1:CAS:528:DyaK1MXntVOhu7w%3D (Pubitemid 29510567)
6. Marple VA, Rubow KL, Olson BA. Inertial, gravitational, centrifugal, and thermal collection techniques. In: Baron PA, Willeke K, editors. Aerosol measurement: principles, techniques and applications. 2nd ed. New York: Wiley Interscience; 2001. p. 229-60.
7. JD Suman BL Laube T Lin G Brouet R Dalby 2002 Relevance of in vitro tests of nasal solutions to predict in vivo deposition Pharm Res 19 1 6 11837692 10.1023/A:1013643912335 1:CAS:528:DC%2BD38XhtVSmsLk%3D (Pubitemid 34075099)
8. JP Mitchell M Nagel 2004 Particle size analysis of aerosols from medicinal inhalers KONA-Powder and Particle 22 32 65
9. Hinds WC. Properties, behavior, and measurement of airborne particles. 2nd ed. New York: Wiley-Interscience; 1999.
10. Heyder J, Svartengren MU. Basic principles of particle behavior in the human respiratory tract. In: Bisgaard H, O'Callaghan C, Smaldone GC, editors. Drug delivery to the lung. New York: Marcel Dekker; 2002. p. 21-45.
11. Adjei AL, Qiu Y, Gupta PK. Bioavailability and pharmacokinetics of inhaled drugs. In: Hickey AJ, editor. Inhalation aerosols: physical and biological basis for therapy. New York: Informa Healthcare; 2007. p. 187-218.
12. FDA-CDER. Draft guidance: metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products chemistry, manufacturing and controls documentation. 1998. Docket 98D-0997. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070573.pdf. Accessed 4 Mar 2011
13. FDA-CDER. Nasal spray and inhalation solution, suspension, and spray drug products chemistry, manufacturing, and controls documentation. 2002. Docket No. 99D-1454. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070575.pdf. Accessed 4 Mar 2011.
14. Fuhrman M, Priore R, Oksana K, Oksana O. Automation of ingredient-specific particle sizing using Raman Chemical Imaging. U.S. Patent Office, January 8, 2010. Patent Application 12/684495.
15. Mansour HM, Hickey AJ. Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review. AAPS PharmSciTechnol. 2007;8(4):Article 99. http://www.aapspharmscitech.org/view.asp?art=pt0804099. Accessed 4 Mar 2011.
16. Baron PA, Mazumder MK, Cheng YS. Direct-reading techniques using optical particle detection. In: Willeke K, Baron PA, editors. Aerosol measurement: principles, techniques and applications. New York: Van Nostrand Reinhold; 1993. p. 381-409.
17. JP Mitchell MW Nagel 1999 Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols J Aerosol Med. 12 4 217 40 10.1089/jam.1999.12.217 10724637 10.1089/jam.1999.12. 217 1:STN:280:DC%2BD3M%2FgtFyisQ%3D%3D
18. BT Chen YS Cheng HC Yeh 1985 Performance of a TSI aerodynamic particle sizer Aerosol Sci Technol. 4 89 97 10.1080/02786828508959041 (Pubitemid 15475917)
19. Harris J, Stein SW, Myrdal PB. Evaluation of the TSI Aerosol Impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers. AAPS PharmSciTechnol. 2006; 7(1): Article 20. doi: 10.1208/pt070120.
20. D Tiwari G Goldman WA Malick PL Madan 1998 Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant Pharm Dev Technol 3 2 163 74 9653753 10.3109/10837459809028492 1:CAS:528:DyaK1cXktlCqt7k%3D (Pubitemid 28310931)
21. A Bouchikhi MH Becquemin Bignon JM Roy A Teillac 1988 Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways Eur Resp J 1 547 52 1:STN:280:DyaL1M%2FgsFGrtA%3D%3D
22. Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, Next Generation Pharmaceutical Impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTechnol. 2003;4:Article 54.
23. SW Stein PB Myrdal 2004 A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions J Pharm Sci 93 2158 75 15236462 10.1002/jps.20116 1:CAS:528:DC%2BD2cXmvVKktbo%3D (Pubitemid 39045494)
24. C Terzano F Mannino 1999 Aerosol characterization of three corticosteroid MDIs with Volumatic™ holding chamber and MDIs alone at two inspiratory flow rates J Aerosol Med. 12 4 249 54 10.1089/jam.1999.12.249 10724639 10.1089/jam.1999.12.249 1:STN:280:DC%2BD3M%2FgtFyitw%3D%3D
25. PB Myrdal SW Stein E Mogalian, et al. 2004 Comparison of the TSI Model 3306 Impactor Inlet with the Andersen cascade impactor: solution metered dose inhalers Drug Dev. Ind. Pharm. 30 859 68 15521331 10.1081/DDC-200034575 1:CAS:528:DC%2BD2cXotVektLw%3D (Pubitemid 39362870)
26. E Mogalian PB Myrdal 2005 Application of USP inlet extensions to the TSI Impactor System 3306/3320 using HFA 227 based metered dose inhalers Drug Dev. Ind. Pharm. 31 977 85 16316853 10.1080/03639040500306211 1:CAS:528: DC%2BD2MXht1GltLvN (Pubitemid 41759209)
27. PB Myrdal E Mogalian JP Mitchell M Nagel C Wright B Kiser, et al. 2006 Application of heated inlet extensions to the TSI 3306/3321 system: comparison with the Andersen cascade impactor and next generation impactor J. Aerosol Med. 19 4 543 54 10.1089/jam.2006.19.543 17196082 10.1089/jam.2006.19.543 (Pubitemid 46067772)
28. YS Cheng D Yazzie J Gao D Muggli J Etter GJ Rosenthanl 2003 Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology J. Aerosol Med. 16 1 65 73 10.1089/089426803764928374 12737686 10.1089/089426803764928374 1:CAS:528:DC%2BD3sXjsFejur0%3D (Pubitemid 36457655)
29. PJ Kuehl EG Barrett JD McDonald K Rudolph D Vodak D Dobry D Lyon 2010 Formulation development and in vivo evaluation of a new dry powder formulation of albuterol sulphate in beagle dogs Pharm Res 27 894 904 10.1007/s11095-010- 0084-z 20232119 10.1007/s11095-010-0084-z 1:CAS:528:DC%2BC3cXjt1Cisro%3D
30. IA Marshall JP Mitchell WD Griffiths 1991 The behavior of regular-shaped, non-spherical particles in a TSI aerodynamic particle sizer J Aerosol Sci. 22 1 73 89 10.1016/0021-8502(91)90094-X 1:CAS:528:DyaK3MXkvFyit7g%3D
31. Y-S Cheng BT Chen HC Yeh IA Marshall JP Mitchell WD Griffiths 1993 Behavior of compact non-spherical particles in the TSI aerodynamic particle sizer model APS33B: ultra-Stokesian drag forces Aerosol Sci Technol. 19 3 255 67 10.1080/02786829308959634 1:CAS:528:DyaK2cXhtlyit70%3D (Pubitemid 23284684)
32. WD Griffiths PJ Iles NP Vaughan 1986 The behavior of liquid droplets in an APS3300 J Aerosol Sci. 17 6 921 30 10.1016/0021-8502(86)90018-2 1:CAS:528:DyaL2sXmvFGmsA%3D%3D (Pubitemid 17525975)
33. Cheng Y-S, Chen BT, Yeh HC. A study of density effect and droplet deformation in the TSI aerodynamic particle sizer. Aerosol Sci Technol. 1990;12:278-85. http://www.informaworld.com/smpp/ftinterface∼content= a778641175∼fulltext=713240930∼frm=content. Accessed 9 Feb 2011 (Pubitemid 20193864)
34. Ho J Y-W. Fluorescent biological particle detection system. US Patent 5701012. 1997.
35. Baron PA, Mazumder MK, Cheng Y-S. Direct-reading techniques using particle motion and optical detection. In: Baron PA, Willeke K, editors. Aerosol measurement: principles, techniques, and applications. New York: Wiley; 2001. p. 495-535.
36. M Ali 2010 A novel method of characterizing medicinal drug aerosols generated from pulmonary drug delivery devices PDA J Pharm Sci Technol 64 4 364 72 21502037 1:CAS:528:DC%2BC3MXlsFKrsLg%3D
37. VA Philip RC Mehta MK Mazumder PP DeLuca 1997 Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers Int J Pharm 151 2 165 74 10.1016/S0378-5173(96)04879-X 1:CAS:528:DyaK2sXktFWht74%3D (Pubitemid 27223364)
38. D Saini AS Biris PK Srirama MK Mazumder 2007 Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers Pharm Dev Technol 12 1 35 41 17484142 10.1080/10837450601166536 1:CAS:528: DC%2BD2sXis1yqur0%3D (Pubitemid 46902608)
39. VA Philip RC Mehta PP DeLuca MK Mazumder 1997 E-SPART analysis of poly(D, L-lactide-co-glycolide) microspheres formulated for dry powder aerosols Particulate Sci Technol. 15 303 16 10.1080/02726359708906773 (Pubitemid 28449124)
40. Ali M, Sharma R, Srirama PK, Mazumder MK. In-vitro studies of nebulizer aerosol particles deposition as a function of aerodynamic size and electrostatic charge in an anatomical throat cast. Presentation at the Frontiers in Aerosol Dosimetry Research Conference, Beckman Center of the National Academies, Irvine, California, USA, October 24-25, 2005.
41. International Standards Organization, Geneva, Switzerland, Particle size analysis-laser diffraction methods. ISO 13320; 2009.
42. JP Mitchell MW Nagel SC Nichols O Nerbrink 2006 Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers J Aerosol Med. 19 4 409 33 10.1089/jam.2006.19.409 17196072 10.1089/jam.2006.19. 409 1:CAS:528:DC%2BD28XhtlGqtL3M (Pubitemid 46067762)
43. Krarup HG, Bumiller M, Stauffer T. The Malvern Spraytec applied to pharmaceutical spray analysis. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory drug delivery VIII. Raleigh: Davis Horwood International; 2002. p. 505-8.
44. WTJ Kwong SL Ho AL Coates 2000 Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor J. Aerosol Med. 13 4 303 14 10.1089/jam.2000.13.303 11262437 10.1089/jam.2000.13.303 1:STN:280: DC%2BD3M7mt1ertA%3D%3D (Pubitemid 32105616)
45. L Vecellio None D Grimbert MH Becquemin E Boissinot A LePape E Lemarié P Diot 2001 Validation of a laser diffraction method as a substitute for cascade impaction in the European project for a nebulizer standard J Aerosol Med. 14 1 107 14 10.1089/08942680152007954 11495481 10.1089/08942680152007954 1:STN:280:DC%2BD3MvkvVKnsA%3D%3D (Pubitemid 32428975)
46. AR Clark 1995 The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers Int J Pharm 115 69 78 10.1016/0378-5173(94)00255-4
47. US Food and Drug Administration. 1993. CDRH reviewer guidance for nebulizers, metered dose inhalers, spacers and actuators. Rockville: FDA. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm081282.htm. Accessed 4 Mar 2011.
48. European Medicines Agency (EMEA). Guideline on the pharmaceutical quality of inhalation and nasal products. 2006; EMEA/CHMP/QWP/49313/2005 Final. London, UK. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/ 2009/09/WC500003568.pdf. Accessed 4 Mar 2011.
49. US Food and Drug Administration. CDER draft guidance for industry: bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action. Rockville: FDA. 2003. http://www.fda.gov/ohrms/dockets/ac/00/ backgrd/3609b1l.pdf. Accessed 4 Mar 2011.
50. Smart J, Berg E, Nerbrink O, Zuban R, Blakey D, New M. Touchspray™ technology: a comparison of the droplet size measured by cascade impaction and laser diffraction. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory drug delivery VIII. Raleigh: Davis Horwood International; 2002. p. 525-7.
51. Moslemi P, Najafabadi AR, Tajerzadeh H. Evaluations of different parameters that affect droplet size distribution of nasal gel sprays. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory drug delivery VIII. Raleigh: Davis Horwood International; 2002. p. 619-22.
52. De Boer AH, Gjaltema G, Witt W, Frijlink HW. The use of laser diffraction technique for the characterization of the aerosol cloud from inhalation devices. In: Dalby RN, Byron PR, Farr SJ, Peart J, editors. Respiratory drug delivery VII. Raleigh: Serentec; 2000. p. 585-7.
53. X-M Zeng HB MacRitchie C Marriott GP Martin 2006 Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations Pharm Res 23 9 2200 9 16900411 10.1007/s11095-006-9055-9 1:CAS:528:DC%2BD28XptVaisbk%3D
54. S Stevens J Shrimpton M Palmer D Prime B Johal 2007 Accuracy assessments for laser diffraction measurements of pharmaceutical lactose Meas Sci Technol 18 3697 706 10.1088/0957-0233/18/12/004 1:CAS:528:DC%2BD2sXhsValtrfO (Pubitemid 350115867)
55. FM Etzler R Deanne 1997 Particle size analysis: a comparison of various methods Part Part Syst Char. 14 278 82 10.1002/ppsc.19970140604 1:CAS:528:DyaK1cXjs1CktA%3D%3D (Pubitemid 127597897)
56. Gebhart J. Optical-direct reading techniques: light intensity systems. In: Baron PA, Willeke K, editors. Aerosol measurement: principles, techniques, and applications. New York: Wiley; 2001. p. 313-44.
57. Mitchell J, Ashcroft J, Fromentin A, Holmes R, Marsault P, McAughey JJ, et al. Laboratory intercomparison of Polytec optical aerosol analyzers. In: Masuda S, Takahashi K, editors. Proc. 3rd Int. Aerosol Conf. Kyoto, Japan. Oxford: Pergamon; 1990. p. 643-6.
58. H Umhauer 1983 Particle size distribution analysis by scattered light measurements using an optically defined measuring volume J Aerosol Sci. 14 765 70 10.1016/0021-8502(83)90060-5 (Pubitemid 14502818)
59. R Jaenicke 1972 The optical particle counter: cross-sensitivity and coincidence J Aerosol Sci. 3 2 95 111 10.1016/0021-8502(72)90147-4
60. Rader DJ, O'Hern TJ. Optical direct-reading techniques: in situ sensing. In: Willeke K, Baron PA, editors. Aerosol measurement: principles, techniques and applications. New York: Van Nostrand Reinhold; 1993. p. 345-80.
61. JP Mitchell AL Nichols A Van Santen 1989 The characterisation of water-droplet aerosols by polytec optical particle analysers Part Part Syst Charact 6 119 23 10.1002/ppsc.19890060120 10.1002/ppsc.19890060120 1:CAS:528:DyaK3cXptV2k
62. DT Loffert D Ikle HS Nelson 1994 A comparison of commercial jet nebulizers Chest 106 1788 92 7988201 10.1378/chest.106.6.1788 1:STN:280:DyaK2M%2FnvFyitw%3D%3D
63. Jaeger R, Schmidt M, Weiss M. Inhalation aerosol spectrometry (INAS®) for the real-time evaluation of particle size distribution and inhaled drug concentration in therapeutic and toxicologic research. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery-2010. River Grove: Davis Healthcare Int.; 2010. p. 489-93.
64. WM Farmer 1972 Measurement of particle size, number density and velocity using a laser interferometer Appl Optics. 11 2603 12 10.1364/AO.11.002603 1:STN:280:DC%2BC3c%2FmvF2muw%3D%3D
65. CR Negus LE Drain 1982 Mie calculations of the scattered light from a spherical particle traversing a fringe system produced by two intersecting laser beams J Phys D: Applied Physics. 15 375 402 10.1088/0022-3727/15/3/003 (Pubitemid 12510789)
66. WD Bachalo MJ Hauser 1984 Phase/Doppler spray analyzer for simultaneous measurements of drop size and velocity distributions Opt Eng 23 5 583 90 (Pubitemid 15475127)
67. KW Stapleton WH Finlay P Zuberbuhler 1994 An in-vitro method for determining regional dosages delivered by jet nebulizers J Aerosol Med. 7 325 44 10150486 10.1089/jam.1994.7.325 1:STN:280:DyaK2MzjslGisg%3D%3D
68. CA Dunbar AP Watkins JF Miller 1997 An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques J Aerosol Med. 10 4 351 68 10.1089/jam.1997.10.351 10175964 10.1089/jam.1997.10.351 1:STN:280:DyaK1c%2FpslKnug%3D%3D (Pubitemid 28006475)
69. PP Kakade HK Versteeg GK Hargrave P Genova RC Williams D Deaton 2007 Design optimization of a novel pMDI actuator for systemic drug delivery J Aerosol Med. 20 4 460 74 10.1089/jam.2007.0595 18158718 10.1089/jam.2007.0595 1:CAS:528:DC%2BD1cXhtFCqtw%3D%3D
70. JA Ranucci FC Chen 1993 Phase Doppler anemometry: a technique for determining aerosol plume-particle size and velocity Pharm Technol. 17 62 1:CAS:528:DyaK2MXjs1ykt7k%3D 64,68,70,72,74
71. TE Corcoran R Hitron W Humphrey N Chigier 2000 Optical measurement of nebulizer sprays: a quantitative comparison of diffraction, phase Doppler interferometry, and time of flight techniques J Aerosol Sci. 31 1 35 50 10.1016/S0021-8502(99)00030-0 1:CAS:528:DyaK1MXotFShu74%3D
72. US Food and Drug Administration. CDER guidance for industry: nasal spray and inhalation solution, suspension and spray drug products-chemistry, manufacturing and controls documentation. Rockville: FDA; 2002.
73. ISO 13322-1. Particle size analysis-image analysis methods-part 1: static image analysis methods. Geneva: International Standards Organization; 2004.
74. ISO 13322-2. Particle size analysis-image analysis methods-part 2: dynamic image analysis methods. Geneva: International Standards Organization; 2006.
75. McCrone WC, Delly JG. The particle atlas: volume 1, principles and techniques. Chicago: McCrone Research Institute; 1992.
76. Bradbury S. Basic measurement techniques for light microscopy, microscopy handbook 23. Oxford: Royal Microscopy Society, Oxford University Press; 1991.
77. F Chambers A Ali J Mitchell C Shelton S Nichols 2010 Cascade impactor (CI) mensuration-an assessment of the accuracy and precision of commercially available optical measurement systems AAPS PharmSciTechnol. 11 1 472 84 10.1208/s12249-010-9405-0 10.1208/s12249-010-9405-0 1:CAS:528: DC%2BC3cXovFahtrk%3D
78. J Raula A Lähde EI Kauppinen 2009 Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders Int J Pharm 365 18 25 18789380 10.1016/j.ijpharm.2008.08.017 1:CAS:528:DC%2BD1cXhsVKnur%2FM
79. Dalby RN, Tiano SL, Hickey AJ. Medical devices for the delivery of therapeutic aerosols to the lungs. In: Hickey AJ, editor. Inhalation aerosols: physical and biological basis for therapy. New York: Informa Healthcare; 2007. p. 417-44.
80. Kidder LH, Haber KS, Dubois J, Lewis EN. An analysis of agglomeration: morphologically directed Raman microscopy to characterize a dry powder inhaler. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery-2010. River Grove: Davis Healthcare Int.; 2010. p. 633-5.
81. BY Shekounov P Chattopadhyay HHY Tong AHL Chow 2007 Particle size analysis in pharmaceutics: principles, methods and applications Pharm Res 24 2 203 27 10.1007/s11095-006-9146-7 10.1007/s11095-006-9146-7 (Pubitemid 46072181)
82. Priore RJ, Olkhovyk O, Klueva O, Fuhrman M. Automation of ingredient-specific particle sizing employing Raman chemical imaging. In: Dalby RN, Byron PR, Peart J, Suman JD, Young PM, editors. Respiratory drug delivery Europe 2009. River Grove: Davis Healthcare Int.; 2009. p. 275-8.
83. Getting to know Advair. ChemImage Pharma Focus: February Issue 2010. http://www.chemimage.com/news/newsletter/pharma-focus/feb2010.aspx. Accessed 4 Mar 2011.
84. Sasic S, Harding L. Global illumination Raman chemical imaging of a combination dry powder formulation. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery-2010. River Grove: Davis Healthcare Int.; 2010. p. 729-32.
85. Valet O, Lankers M, Adi H, Traini D. Young PM. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery-2010. River Grove: Davis Healthcare Int.; 2010. p. 763-6.
86. Priore RJ, Klueva O, Olkhovyk O, Fuhrman M. Ingredient-specific particle sizing of Combivent® metered dose inhaler. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, editors. Respiratory drug delivery-2010. River Grove: Davis Healthcare Int.; 2010. p. 499-502.
87. W Doub WP Adams JA Spencer LF Buhse MP Nelson PJ Treado 2007 Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report Pharm Res 24 5 934 45 10.1007/s11095-006-9211-2 17372686 10.1007/s11095-006-9211-2 1:CAS:528:DC%2BD2sXkslWgtLo%3D (Pubitemid 46675394)
88. US Pharmacopeia. <429> Light diffraction measurement of particle size. USP33, NF28. Rockville: US Pharmacopeial Convention; 2003.
89. US Pharmacopeia. In-process revision to Chapter <601> Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers. Pharm.Forum. 2011;37(4). http://www.usppf.com/pf/pub/data/v374/CHA-IPR-374-c601.xml. Accessed 18 July 2011.
90. European Directorate for Quality in Medicines and Healthcare (EDQM) 2006 Preparations for nebulisation: characterisation, general chapter 2.9.44 Pharmeuropa 18 2 280 2
91. United States Pharmacopeial Convention 2010 In process revision. <1601> Products for nebulization-characterization tests Pharm Forum. 36 2 534 9
92. United States Pharmacopeia. <776> Optical microscopy. USP33, NF28. Rockville: US Pharmacopeial Convention; 2009.
93. United States Pharmacopeia. <1181> Scanning electron microscopy. USP33, NF28. Rockville: US Pharmacopeial Convention; 2009.